Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat (NCT02890069) | Novartis Pharmaceuticals | 2016-10-14 |
Track Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.